Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,109 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 35,109 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.58 | $38.70 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,198 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 17, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.58 | $38.70 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,183 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 16, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.66 | $39.90 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,168 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 15, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.71 | $40.65 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,153 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 12, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.67 | $40.05 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,138 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 11, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.83 | $42.45 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,123 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 10, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.94 | $44.10 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,108 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 09, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $3.21 | $48.15 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,093 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 08, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.95 | $44.25 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,078 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 05, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.71 | $40.65 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,063 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 04, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.73 | $40.95 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,048 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 03, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.71 | $40.65 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,033 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 02, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.63 | $39.45 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,018 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| November 01, 2021 Filed Dec 3, 2021 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.67 | $40.05 |
DisclosureSEC source: 0001209191-21-067892 · doc4.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,003 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 29, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.72 | $40.80 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,988 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 28, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.61 | $39.15 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,975 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 27, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.61 | $39.15 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,958 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 26, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.64 | $39.60 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,943 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 25, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.64 | $39.60 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,928 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 22, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.66 | $39.90 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,913 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 21, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.65 | $39.75 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,898 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 20, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.63 | $39.45 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,883 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 19, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.76 | $41.40 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,868 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 18, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.75 | $41.25 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,853 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 15, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.76 | $41.40 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,838 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 14, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.81 | $42.15 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,823 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 13, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.71 | $40.65 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,808 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 12, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.71 | $40.65 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,793 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 11, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.73 | $40.95 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,778 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 08, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.84 | $42.60 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,763 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 07, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.76 | $41.40 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,748 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 06, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.76 | $41.40 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,733 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 05, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.82 | $42.30 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,718 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 04, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.87 | $43.05 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,703 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| October 01, 2021 Filed Nov 5, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.69 | $40.35 |
DisclosureSEC source: 0001209191-21-063225 · doc4.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,688 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.72 | $40.80 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,673 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.82 | $42.30 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,658 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 28, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.76 | $41.40 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,643 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 27, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.79 | $41.85 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,628 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 24, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.74 | $41.10 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,613 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 23, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.75 | $41.25 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,598 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 22, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.76 | $41.40 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,583 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 21, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.81 | $42.15 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,568 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 20, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.82 | $42.30 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,553 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 17, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.85 | $42.75 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,538 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 16, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.91 | $43.65 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,523 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 15, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.86 | $42.90 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,508 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 14, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $3.02 | $45.30 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,493 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 13, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.96 | $44.40 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,478 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| September 10, 2021 Filed Oct 1, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $2.78 | $41.70 |
DisclosureSEC source: 0001209191-21-058521 · doc4.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,463 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.